MLH1 and MSH2 are important genes for DNA mismatch repair and crossing over during meiosis and are implicated in male infertility. Therefore, the methylation patterns of the DNA mismatch repair genes MLH1 and MSH2 in oligozoospermic males were investigated. Ten oligozoospermic patients and 29 normozoospermic donors were analysed. Methylation profiles of the MLH1 and MSH2 promotors were analysed. In addition, sperm motility and seminal reactive oxygen species (ROS) were recorded.
ation between idiopathic male infertility and epigenetic modifications, including promoter methylation in imprinted, reproduction-related and developmental genes in spermatozoa and might explain cases of idiopathic male infertility (Gunes, Arslan, Hekim, & Asci, 2016; Jenkins et al., 2016; Urdinguio et al., 2015) .
The DNA mismatch repair (DMMR) mechanism is essential for maintaining cell genomic stability. DMMR proteins remove base substitution mismatches and insertion-deletion loops during replication and recombination. Mismatches occur during the DNA replication process by escaping the proofreading function of DNA polymerase III.
These mismatches result in mispairing, including G-T or A-C. Mismatch repair (MMR) is also implicated in cell cycle arrest and apoptosis after DNA damage (Gunes, Al-Sadaan, & Agarwal, 2015) . Therefore, defects in DMMR during spermatogenesis may disturb the integrity of the sperm DNA.
Abnormally high amounts of reactive oxygen species (ROS) are detected in approximately 50% of the infertile patients (Homa, Vessey, Perez-Miranda, Riyait, & Agarwal, 2015) . It is also known that high levels of ROS production lead to DNA damage and silencing of DMMR genes in spermatozoa (Homa et al., 2015; Vessey, PerezMiranda, Macfarquhar, Agarwal, & Homa, 2014) . Infertile men with high ROS levels in their ejaculate also present with a higher percentage of DNA-damaged spermatozoa than fertile males (Wang et al., 2003) .
In an attempt to understand the relationship between the methylation status, seminal ROS and oligozoospermia, we hypothesised that transcriptional inactivation or silencing of DMMR genes during spermatogenesis may disturb this process, thus resulting in oligozoospermia. In addition, it has been hypothesised that high concentrations of ROS may cause hypermethylation of promoter DMMR genes and may result in downregulation of enzymes through transcriptional silencing (Min, Lim, & Jung, 2010) . To investigate this hypothesis, we have compared promoter methylation patterns of MutL homolog 1 (MLH1) and MutS homolog 2 (MSH2) in spermatozoa from oligozoospermic men.
Therefore, this study aimed at comparing the promoter methylation patterns of MLH1 and MSH2 genes in spermatozoa between oligozoospermic and normozoospermic men and to evaluate the role of seminal ROS levels on this possible association.
| MATERIALS AND METHODS

| Study group
The study protocol was approved by the Institutional Review Board of the Cleveland Clinic. Ten males with idiopathic oligozoospermia (sperm concentration < 10 × 10 6 /ml) attending the Andrology Clinic of Cleveland Clinic and 29 normozoospermic (sperm concentration >15 × 10 6 /ml) controls (donors) were enrolled in this study. Informed consent was obtained from all participants. Semen samples were collected in sterile containers after a period of ejaculatory abstinence of 2-4 days. The exclusion criteria included a history of maldescended testes, testicular trauma or surgery, absence of secondary sexual characteristics, presence of varicocele, genito-urinary infection, leukocytospermia, use of gonadotoxic medication, endocrine disorders and any other identifiable causes of male infertility.
After complete liquefaction of the ejaculate for 20-30 min at 37°C, all specimens were first assessed for volume, sperm concentration, total sperm count, sperm motility and round cell concentration according to World Health Organization (WHO) guidelines (World Health Organization, 2010) . Sperm motility and concentration were assessed using a MicroCell counting chamber (Vitrolife, San Diego, CA). Samples were tested for leukocytospermia (>1 × 10 6 WBC/ml) when the round cell concentration was >1 × 10 6 /ml (Groen et al., 2016) . Subsequently, specimens were assessed seminal ROS production and sperm methylation profiles of MLH1 and MSH2 promoters, as below.
| ROS measurement
Reactive oxygen species levels were measured within one hour of collection with a chemiluminescence assay using luminol [(5-amino- (Agarwal, Ahmad, & Sharma, 2015) .
| Somatic cell lyses
The aim of this procedure was to separate the germ cells from so- 
| DNA isolation
After elimination of somatic cells, the DNA of sperm samples was isolated with Zymo Research Quick-gDNA™ MiniPrep (Irvine, CA, USA) according to the manufacturer's instructions (Yegin, Gunes, & Buyukalpelli, 2013) . In brief, specimens were first incubated in 400 μl genomic lysis buffer for 5-10 min at room temperature, followed by centrifugation and two washing steps. Finally, sperm DNA was eluted with elution buffer and both the DNA concentration and its purity were measured using a NanoDrop spectrophotometer [Thermo Scientific 2000c (Waltham, MA, USA)]. DNA samples were stored at −80°C until bisulphite modification.
| Bisulphite modification and methylation-specific polymerase chain reaction (MSP)
Bisulphite modification of extracted DNA samples was carried out using the EZ DNA Methylation-Gold™ Kit (Zymo Research, Irvine, CA, USA). Approximately 500 ng DNA/20 μl were used for bisulphite modification (Yegin et al., 2013) . MSP was run for the promoter regions of both MLH1 and MSH2 genes using methylated and unmethylated primer pairs. The primer sequences used in the analysis of MLH1 and MSH2 genes are listed in Table 1 . 
| Statistical analysis
| RESULTS
Sperm concentration, sperm motility, ejaculate volume and seminal ROS levels for the 10 oligozoospermic men and 29 normozoospermic donors are depicted in Table 2 .
Sperm concentration, motility and ROS levels were significantly different between the groups of oligozoospermic patients and normozoospermic donors ( Table 2 ). The percentage of MLH1 promoter methylation in patients with oligozoospermia was significantly higher than in normozoospermic men (p = .0013) (Table 3) . Overall, 40%
(4/10) of oligozoospermic infertile men had hypermethylation in their sperm DNA while none of the normozoospermic controls had methylation in MLH1 promoter (Table 3 
| DISCUSSION
Spermatogenesis is a complex and sensitive process of proliferation and differentiation of male germ cells involving replication, mitosis, meiosis and spermatogenesis (Chocu, Calvel, Rolland, & Pineau, 2012; Nussbaum, McInnes, Willard, & Hamosh, 2007) . ROS, exogenous agents and abnormal sperm chromatin packaging result in poor sperm development and sperm nuclear DNA damage. Although the integrity of the sperm genome and stability of the male germ cell are generally protected by DNA repair mechanisms, recent studies have shown an association between idiopathic male infertility and aberrant DNA methylation of the whole genome or some genes in human spermatozoa (Gunes et al., 2016) .
In this study, we have analysed the methylation patterns of the MLH1 and MSH2 genes in sperm samples of oligozoospermic and normozoospermic men. Our results suggest a significant promoter methylation in the MLH1 gene in oligozoospermic patients compared to normozoospermic controls. We also observed a significant positive association between elevated ROS levels and MLH1 gene methylation, but not with MSH2 promoter methylation. To the best of our know ledge, this is the first study indicating an association among promoter methylation of MLH, elevated levels ROS and oligozoospermia.
MLH1 is a DMMR protein involved in recombination between homologue chromosomes (Sun et al., 2007) . Deficiency or absence of MLH1 gene was reported to be associated with gametogenesis failure in humans due to meiotic arrest at pachytene level, thus resulting in reduced chiasma formation (Ferguson, Leung, Jiang, & Ma, 2009 ).
Infertile men with altered MLH1 distribution were also shown to have unsynapsed autosomal meiotic chromosomes and increased sperm aneuploidy rates (Ferguson et al., 2009) . Similarly, tagged polymorphisms in MLH1 were shown to be associated with male infertility and sperm DNA damage (Ji et al., 2012) . Recombination-induced doublestrand breaks (DSB) and crossing over and then ligation of strands once again. Failure in ligation of these DNA strands may be deleterious during spermatogenesis and result in infertility (Cohen & Pollard, 2001; Marcon & Moens, 2005) .
Immunohistochemistry studies reveal genomic instability and defects in MLH1 and MSH2 in nonobstructive azoospermic men. The proteins are mislocalised or absent in both germ cells and somatic cells (Maduro et al., 2003) . Infertile patients with high seminal ROS levels usually present with low sperm counts compared with fertile males (Agarwal, Mulgund, Sharma, & Sabanegh, 2014 ).
In addition to human studies, deletion of MLH1 results in disrupted spermatogenesis, meiotic arrest and infertility in mice (Baker et al., 1996; Edelmann et al., 1999) . In the mice, MLH1 is located at meiotic crossing over sites and is involved in meiosis (Svetlanov & Cohen, 2004 ). Mukherjee and colleagues have reported that deletions of the MLH1 gene result in microsatellite instability and infertility (Mukherjee, Ridgeway, & Lamb, 2010) . MLH1-deficient and MSH2-knockout mice exhibit microsatellite instability and infertility due to meiotic arrest at pachytene and disruption of normal chromosomal synapses (Baker et al., 1995; Mukherjee et al., 2010) .
MSH2 is highly expressed in the mouse in spermatogonia and spermatocytes (Paul et al., 2007) . In one study, an association between DMMR deficiency of MSH2 gene in somatic cells and loss of some germ cells was reported (Ji et al., 2012) . MSH2-knockout mouse models demonstrated elevated predisposition to ultraviolet (UV) radiation-induced skin cancer or tumorigenesis without abnormalities in spermatogenesis (Paul et al., 2007) . Similarly, our results have demonstrated no association among oligozoospermia and MSH2 promoter methylation in oligozoospermic men compared to normal controls.
Finally, it is important to note that the present study is limited by the small sample size as well as the nonquantitative nature of the detection of the methylation status. These results are preliminary and part of a broader ongoing project to assess the role of MLH1 and MSH2 genes in idiopathic male infertility and must be verified in larger cohort using other techniques.
Epigenetic alterations in spermatozoa can be associated with idiopathic oligozoospermia, abnormal sperm morphology and decreased progressive motility. The epigenetic profile of spermatozoa may also affect the health of offspring as epigenetic aberrations are heritable. Although the exact cause and effect relationship between epigenetics and male infertility have not been elucidated, further investigation of this area holds a significant potential and great promise for understanding the molecular mechanisms of infertility. An epigenetic approach during the male infertility investigation can be useful because unlike the genetic changes including mutations, DNA methylation and histone modifications are epigenetic changes, which are reversible (Enokida & Nakagawa, 2008) . This reversibility makes epigenetic changes attractive candidates for infertility treatment.
In conclusion, our preliminary data indicate that the methylation pattern of MLH1 gene may have a role in oligozoospermia.
Large cohorts and well-defined phenotypes are required to reveal the possible role of the methylation pattern of MSH2. However, further studies are warranted to understand the molecular mechanisms involved in the development of oligozoospermia as male infertility factor.
ACKNOWLEDGEMENT
This study was supported by the financial support from the American Center for Reproductive Medicine, Department of Urology at Cleveland Clinic Foundation.
